Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Ganglioneuroblastoma 1

Interventions

Magnetic Resonance Spectroscopy 2sargramostim 1iberdomide 1dinutuximab 1Topotecan 1Specimen Handling 1Cyclophosphamide 1Colony-Stimulating Factors 1Biopsy 13-fluorobenzylguanidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Ganglioneuroblastoma × 3-fluorobenzylguanidine × Clear all
NCT06858501 2026-03-19

Comparing 123I-MIBG and 18F-MFBG Imaging in Patients With Newly Diagnosed, High Risk Neuroblastoma

Children's Oncology Group

Phase 2 Not yet recruiting
84 enrolled
CNS

Ganglioneuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡